Gadolinium-Incorporated Carbon Nanodots for T 1 -Weighted Magnetic Resonance Imaging
Ding-Kun Ji,Giacomo Reina,Hanyu Liang,Da Zhang,Shi Guo,Belén Ballesteros,Cécilia Ménard-Moyon,Juan Li,Alberto Bianco,Belén Ballesteros,Cécilia Ménard-Moyon
DOI: https://doi.org/10.1021/acsanm.0c02993
IF: 6.14
2021-01-15
ACS Applied Nano Materials
Abstract:The design and development of contrast agents for magnetic resonance imaging (MRI) with improved chemical stability and higher contrasting capability for clinical translation compared to conventional contrast agents are still of great interest. In this study, a facile and universal approach was explored for controllable functionalization of red-emissive carbon nanodots (RCNDs) with diethylenetriaminepentaacetic anhydride (DTPA) for chelation of gadolinium. A series of accurate characterizations were used to control each step of the synthesis. The functionalization did not alter the band gap of the carbon nanodots, preserving their inherent far-red fluorescence. The as-prepared RCND-DTPA-Gd displayed a high colloidal stability with negligible Gd leakage. The nanodots also showed a better magnetic resonance relaxivity than commercial MRI agents. RCND-DTPA-Gd had good biocompatibility <i>in vivo</i> even at high doses. The systemically injected RCND-DTPA-Gd were found to be efficiently excreted through the renal route, a feature that further minimizes the potential toxicity risks. All these properties suggest that carbon nanodots can be well designed as efficient carriers of Gd, resulting in potential clinical tools as dual MRI/fluorescence functional probes for imaging applications. The approach described here could pave the pathway to a flexible strategy for the controllable functionalization of small-sized nanoparticles including carbon dots, rendering them more versatile. This work is expected to promote the future translation of carbon nanodots into clinical trials.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsanm.0c02993?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsanm.0c02993</a>.Organ distribution of RCND-DTPA-Gd in vivo (Videos S1 and S2) (<a class="ext-link" href="/doi/suppl/10.1021/acsanm.0c02993/suppl_file/an0c02993_si_001.zip">ZIP</a>)Synthesis of DTPA ligand (Scheme S1), additional HAADF-STEM images of the RCND-DTPA-Gd sample (Figure S1), DLS of RCND-DTPA-Gd (Figure S2), FL spectra of CND-DTPA-Gd (Figure S3), cell viability of RCND-DTPA-Gd (Figure S4), and the hematological and biochemical parameters of RCND-DTPA (Tables S1 and S2) (<a class="ext-link" href="/doi/suppl/10.1021/acsanm.0c02993/suppl_file/an0c02993_si_002.pdf">PDF</a>)This article has not yet been cited by other publications.
materials science, multidisciplinary,nanoscience & nanotechnology